Ronald Todd Plott
Director · Phio Pharmaceuticals Corp.
IndividualBuying only
- 2026
- Sep 30, 2026
- 3
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Ronald Todd Plott files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Robert J. Bitterman - $45K in PHIO purchases and sales in the last 12 months
- Patricia A. Bradford - $19K in PHIO purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Ronald Todd Plott?
Ronald Todd Plott is a corporate insider, tracked as Director of Phio Pharmaceuticals Corp. (PHIO). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Ronald Todd Plott submitted recently?
3 primary Form 4 filings in the last 90 days, covering 1 company.
Has Ronald Todd Plott been buying or selling stock?
Recorded transactions: 3 open-market purchases ($27K) and 0 open-market sales across all tracked filings.
